Survival and Clinical Outcome of Patients with Neuroendocrine Tumors of the Gastroenteropancreatic Tract in a German Referral Center
- 1 April 2004
- journal article
- research article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1014 (1) , 222-233
- https://doi.org/10.1196/annals.1294.025
Abstract
Neuroendocrine tumors (NETs) are rare neoplasms. Approximately 75% of all cases manifest in the gastroenteropancreatic (GEP) system. Because of the low incidence of NETs, limited data abou...Keywords
This publication has 30 references indexed in Scilit:
- A 5‐decade analysis of 13,715 carcinoid tumorsCancer, 2003
- Epidemiology and survival in patients with carcinoid disease in the NetherlandsAnnals of Oncology, 2001
- Management of Nonfunctioning Islet Cell CarcinomasWorld Journal of Surgery, 2000
- Epidemiology of carcinoid neoplasms in Vaud, Switzerland, 1974–97British Journal of Cancer, 2000
- Carcinoid tumors: Analysis of prognostic factors and survival in 301 patients from a referral centerAnnals of Oncology, 1997
- Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours.Gut, 1996
- Revised classification of neuroendocrine tumours of the lung, pancreas and gutVirchows Archiv, 1995
- The epidemiology of carcinoid tumours in England and ScotlandBritish Journal of Cancer, 1994
- Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell CarcinomaNew England Journal of Medicine, 1992
- THE CLASSIFICATION OF CARCINOID TUMOURSThe Lancet, 1963